Titre : Chromatographie en phase liquide

Chromatographie en phase liquide : Questions médicales fréquentes

Termes MeSH sélectionnés :

Keratoconus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Chromatographie en phase liquide : Questions médicales les plus fréquentes", "headline": "Chromatographie en phase liquide : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Chromatographie en phase liquide : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-16", "dateModified": "2025-03-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Chromatographie en phase liquide" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Chromatographie", "url": "https://questionsmedicales.fr/mesh/D002845", "about": { "@type": "MedicalCondition", "name": "Chromatographie", "code": { "@type": "MedicalCode", "code": "D002845", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromatographie d'affinité", "alternateName": "Chromatography, Affinity", "url": "https://questionsmedicales.fr/mesh/D002846", "about": { "@type": "MedicalCondition", "name": "Chromatographie d'affinité", "code": { "@type": "MedicalCode", "code": "D002846", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181.400.170" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Purification par affinité en tandem", "alternateName": "Tandem Affinity Purification", "url": "https://questionsmedicales.fr/mesh/D000078791", "about": { "@type": "MedicalCondition", "name": "Purification par affinité en tandem", "code": { "@type": "MedicalCode", "code": "D000078791", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181.400.170.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Chromatographie sur gel", "alternateName": "Chromatography, Gel", "url": "https://questionsmedicales.fr/mesh/D002850", "about": { "@type": "MedicalCondition", "name": "Chromatographie sur gel", "code": { "@type": "MedicalCode", "code": "D002850", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181.400.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromatographie sur agarose", "alternateName": "Chromatography, Agarose", "url": "https://questionsmedicales.fr/mesh/D002847", "about": { "@type": "MedicalCondition", "name": "Chromatographie sur agarose", "code": { "@type": "MedicalCode", "code": "D002847", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181.400.250.200" } } } ] }, { "@type": "MedicalWebPage", "name": "Chromatographie en phase liquide à haute performance", "alternateName": "Chromatography, High Pressure Liquid", "url": "https://questionsmedicales.fr/mesh/D002851", "about": { "@type": "MedicalCondition", "name": "Chromatographie en phase liquide à haute performance", "code": { "@type": "MedicalCode", "code": "D002851", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181.400.300" } } }, { "@type": "MedicalWebPage", "name": "Chromatographie d'échange d'ions", "alternateName": "Chromatography, Ion Exchange", "url": "https://questionsmedicales.fr/mesh/D002852", "about": { "@type": "MedicalCondition", "name": "Chromatographie d'échange d'ions", "code": { "@type": "MedicalCode", "code": "D002852", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181.400.383" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromatographie sur DEAE-cellulose", "alternateName": "Chromatography, DEAE-Cellulose", "url": "https://questionsmedicales.fr/mesh/D002848", "about": { "@type": "MedicalCondition", "name": "Chromatographie sur DEAE-cellulose", "code": { "@type": "MedicalCode", "code": "D002848", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181.400.383.349" } } } ] }, { "@type": "MedicalWebPage", "name": "Chromatographie sur papier", "alternateName": "Chromatography, Paper", "url": "https://questionsmedicales.fr/mesh/D002854", "about": { "@type": "MedicalCondition", "name": "Chromatographie sur papier", "code": { "@type": "MedicalCode", "code": "D002854", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181.400.454" } } }, { "@type": "MedicalWebPage", "name": "Chromatographie en phase inverse", "alternateName": "Chromatography, Reverse-Phase", "url": "https://questionsmedicales.fr/mesh/D056148", "about": { "@type": "MedicalCondition", "name": "Chromatographie en phase inverse", "code": { "@type": "MedicalCode", "code": "D056148", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181.400.495" } } }, { "@type": "MedicalWebPage", "name": "Chromatographie sur couche mince", "alternateName": "Chromatography, Thin Layer", "url": "https://questionsmedicales.fr/mesh/D002855", "about": { "@type": "MedicalCondition", "name": "Chromatographie sur couche mince", "code": { "@type": "MedicalCode", "code": "D002855", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.196.181.400.537" } } } ], "about": { "@type": "MedicalCondition", "name": "Chromatographie en phase liquide", "alternateName": "Chromatography, Liquid", "code": { "@type": "MedicalCode", "code": "D002853", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mirjana Minceva", "url": "https://questionsmedicales.fr/author/Mirjana%20Minceva", "affiliation": { "@type": "Organization", "name": "Biothermodynamics, TUM School of Life Sciences Weihenstephan, Technical University of Munich, Maximus-von-Imhof-Forum 2, 85354 Freising, Germany. Electronic address: mirjana.minceva@tum.de." } }, { "@type": "Person", "name": "Melanie Gerigk", "url": "https://questionsmedicales.fr/author/Melanie%20Gerigk", "affiliation": { "@type": "Organization", "name": "Biothermodynamics, TUM School of Life Sciences, Technical University of Munich, 85354 Freising, Germany." } }, { "@type": "Person", "name": "Simon Vlad Luca", "url": "https://questionsmedicales.fr/author/Simon%20Vlad%20Luca", "affiliation": { "@type": "Organization", "name": "Biothermodynamics, TUM School of Life Sciences, Technical University of Munich, 85354 Freising, Germany." } }, { "@type": "Person", "name": "Shengqiang Tong", "url": "https://questionsmedicales.fr/author/Shengqiang%20Tong", "affiliation": { "@type": "Organization", "name": "College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310032, China. Electronic address: sqtong@zjut.edu.cn." } }, { "@type": "Person", "name": "Gert Desmet", "url": "https://questionsmedicales.fr/author/Gert%20Desmet", "affiliation": { "@type": "Organization", "name": "Department of Chemical Engineering, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussel, Belgium." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "[Keratoconus: biomechanics ex vivo].", "datePublished": "2023-05-05", "url": "https://questionsmedicales.fr/article/37146635", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-2062-3633" } }, { "@type": "ScholarlyArticle", "name": "Artificial intelligence for detecting keratoconus.", "datePublished": "2023-11-15", "url": "https://questionsmedicales.fr/article/37965960", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD014911.pub2" } }, { "@type": "ScholarlyArticle", "name": "Biomechanics of keratoconus: Two numerical studies.", "datePublished": "2023-02-02", "url": "https://questionsmedicales.fr/article/36730305", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0278455" } }, { "@type": "ScholarlyArticle", "name": "Keratoconus tomographic indices in osteogenesis imperfecta.", "datePublished": "2023-04-19", "url": "https://questionsmedicales.fr/article/37074408", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00417-023-06059-4" } }, { "@type": "ScholarlyArticle", "name": "Keratoconus in two siblings with congenital distichiasis.", "datePublished": "2023-03-08", "url": "https://questionsmedicales.fr/article/36891581", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/11206721231162441" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Techniques d'investigation", "item": "https://questionsmedicales.fr/mesh/D008919" }, { "@type": "ListItem", "position": 3, "name": "Techniques de chimie analytique", "item": "https://questionsmedicales.fr/mesh/D002623" }, { "@type": "ListItem", "position": 4, "name": "Chromatographie", "item": "https://questionsmedicales.fr/mesh/D002845" }, { "@type": "ListItem", "position": 5, "name": "Chromatographie en phase liquide", "item": "https://questionsmedicales.fr/mesh/D002853" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Chromatographie en phase liquide - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Chromatographie en phase liquide", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Chromatographie en phase liquide", "description": "Comment la chromatographie en phase liquide est-elle utilisée en diagnostic ?\nQuels types d'échantillons peuvent être analysés ?\nQuels sont les avantages de cette méthode pour le diagnostic ?\nPeut-on utiliser cette technique pour des médicaments ?\nLa chromatographie en phase liquide peut-elle détecter des toxines ?", "url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Keratoconus&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Chromatographie en phase liquide", "description": "Quels symptômes peuvent indiquer un besoin d'analyse par chromatographie ?\nLa chromatographie peut-elle aider à diagnostiquer des allergies ?\nQuels symptômes sont liés à des déséquilibres hormonaux ?\nPeut-on détecter des maladies métaboliques avec cette technique ?\nQuels symptômes peuvent indiquer une intoxication médicamenteuse ?", "url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Keratoconus&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Chromatographie en phase liquide", "description": "Comment la chromatographie contribue-t-elle à la prévention des maladies ?\nPeut-on utiliser cette technique pour le dépistage précoce ?\nQuels programmes de santé publique utilisent la chromatographie ?\nLa chromatographie peut-elle aider à prévenir les intoxications ?\nComment cette technique aide-t-elle à la recherche en santé publique ?", "url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Keratoconus&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Chromatographie en phase liquide", "description": "La chromatographie en phase liquide est-elle utilisée dans le traitement ?\nComment cette technique aide-t-elle à ajuster les traitements ?\nPeut-on utiliser la chromatographie pour évaluer l'efficacité d'un traitement ?\nQuels traitements peuvent être surveillés par cette méthode ?\nLa chromatographie peut-elle aider à détecter des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Keratoconus&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Chromatographie en phase liquide", "description": "Quelles complications peuvent survenir lors de l'utilisation de cette technique ?\nLa chromatographie peut-elle causer des effets indésirables ?\nQuels risques sont associés à l'échantillonnage ?\nComment minimiser les complications lors de l'analyse ?\nLes résultats erronés peuvent-ils entraîner des complications cliniques ?", "url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Keratoconus&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Chromatographie en phase liquide", "description": "Quels facteurs de risque influencent l'analyse par chromatographie ?\nL'âge peut-il être un facteur de risque pour certaines analyses ?\nLes habitudes alimentaires affectent-elles les résultats ?\nLe mode de vie peut-il impacter les résultats d'analyse ?\nLes médicaments pris peuvent-ils influencer les résultats ?", "url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Keratoconus&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment la chromatographie en phase liquide est-elle utilisée en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'analyser des échantillons biologiques pour détecter des substances spécifiques." } }, { "@type": "Question", "name": "Quels types d'échantillons peuvent être analysés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échantillons de sang, d'urine, de tissus et d'autres fluides biologiques." } }, { "@type": "Question", "name": "Quels sont les avantages de cette méthode pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elle offre une haute résolution et une grande sensibilité pour détecter des analytes." } }, { "@type": "Question", "name": "Peut-on utiliser cette technique pour des médicaments ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est couramment utilisée pour analyser des médicaments dans le plasma." } }, { "@type": "Question", "name": "La chromatographie en phase liquide peut-elle détecter des toxines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est efficace pour identifier des toxines dans divers échantillons." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un besoin d'analyse par chromatographie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes inexpliqués, intoxications ou réactions indésirables aux médicaments." } }, { "@type": "Question", "name": "La chromatographie peut-elle aider à diagnostiquer des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut identifier des allergènes dans des échantillons biologiques." } }, { "@type": "Question", "name": "Quels symptômes sont liés à des déséquilibres hormonaux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, changements de poids, et irrégularités menstruelles peuvent être des indicateurs." } }, { "@type": "Question", "name": "Peut-on détecter des maladies métaboliques avec cette technique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet d'analyser des métabolites pour diagnostiquer des maladies métaboliques." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une intoxication médicamenteuse ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Nausées, vomissements, confusion et troubles respiratoires peuvent survenir." } }, { "@type": "Question", "name": "Comment la chromatographie contribue-t-elle à la prévention des maladies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de détecter précocement des biomarqueurs de maladies, facilitant l'intervention." } }, { "@type": "Question", "name": "Peut-on utiliser cette technique pour le dépistage précoce ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour le dépistage de maladies comme le diabète et le cancer." } }, { "@type": "Question", "name": "Quels programmes de santé publique utilisent la chromatographie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes de dépistage des drogues et de surveillance des maladies infectieuses." } }, { "@type": "Question", "name": "La chromatographie peut-elle aider à prévenir les intoxications ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet d'analyser des aliments et des médicaments pour détecter des contaminants." } }, { "@type": "Question", "name": "Comment cette technique aide-t-elle à la recherche en santé publique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'analyser des échantillons pour étudier l'épidémiologie des maladies." } }, { "@type": "Question", "name": "La chromatographie en phase liquide est-elle utilisée dans le traitement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, elle aide à surveiller les niveaux de médicaments dans le sang." } }, { "@type": "Question", "name": "Comment cette technique aide-t-elle à ajuster les traitements ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de mesurer la concentration des médicaments pour optimiser les doses." } }, { "@type": "Question", "name": "Peut-on utiliser la chromatographie pour évaluer l'efficacité d'un traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet de quantifier les biomarqueurs et les médicaments dans le corps." } }, { "@type": "Question", "name": "Quels traitements peuvent être surveillés par cette méthode ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements pour le cancer, les maladies infectieuses et les troubles psychiatriques." } }, { "@type": "Question", "name": "La chromatographie peut-elle aider à détecter des effets secondaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut identifier des métabolites associés à des effets indésirables." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir lors de l'utilisation de cette technique ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs d'analyse peuvent mener à des diagnostics erronés ou à des traitements inappropriés." } }, { "@type": "Question", "name": "La chromatographie peut-elle causer des effets indésirables ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle est une méthode analytique et ne cause pas d'effets indésirables directs." } }, { "@type": "Question", "name": "Quels risques sont associés à l'échantillonnage ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des risques d'infection ou de complications liées à la collecte d'échantillons biologiques." } }, { "@type": "Question", "name": "Comment minimiser les complications lors de l'analyse ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "En suivant des protocoles stricts de manipulation et d'analyse des échantillons." } }, { "@type": "Question", "name": "Les résultats erronés peuvent-ils entraîner des complications cliniques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des résultats incorrects peuvent mener à des traitements inappropriés et à des complications." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent l'analyse par chromatographie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "La qualité des échantillons, la technique utilisée et l'expérience de l'opérateur." } }, { "@type": "Question", "name": "L'âge peut-il être un facteur de risque pour certaines analyses ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies sont plus fréquentes chez les personnes âgées, influençant les résultats." } }, { "@type": "Question", "name": "Les habitudes alimentaires affectent-elles les résultats ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'alimentation peut influencer les niveaux de métabolites détectés dans les échantillons." } }, { "@type": "Question", "name": "Le mode de vie peut-il impacter les résultats d'analyse ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme, l'alcool et d'autres facteurs de mode de vie peuvent affecter les résultats." } }, { "@type": "Question", "name": "Les médicaments pris peuvent-ils influencer les résultats ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent interférer avec les analyses et fausser les résultats." } } ] } ] }

Sources (707 au total)

[Keratoconus: biomechanics ex vivo].

Keratoconus is associated with an impairment in corneal biomechanics. Using nanoindentation, spatially resolved measurement of biomechanical properties can be performed on corneal tissue. The aim of t... 17 corneas with keratoconus and 10 healthy corneas unsuitable for transplantation were included in the study. After explantation, corneas were kept in culture medium containing 15% dextran for at leas... A total of 2328 individual indentations were performed for this study. In the keratoconus group; the mean modulus of elasticity was 23.2 kPa (± 15.0 kPa) for a total of 1802 indentations. In the contr... Using nanoindentation, a significantly lower elastic modulus was found in corneas with keratoconus compared to corneas without keratoconus. Further studies are needed to gain a better understanding of...

Artificial intelligence for detecting keratoconus.

Keratoconus remains difficult to diagnose, especially in the early stages. It is a progressive disorder of the cornea that starts at a young age. Diagnosis is based on clinical examination and corneal... To assess the diagnostic accuracy of artificial intelligence (AI) algorithms for detecting keratoconus in people presenting with refractive errors, especially those whose vision can no longer be fully... We included cross-sectional and diagnostic case-control studies that investigated AI for the diagnosis of keratoconus using topography, tomography, or both. We included studies that diagnosed manifest... Two review authors independently extracted the study data and assessed the quality of studies using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. When an article contained mul... We included 63 studies, published between 1994 and 2022, that developed and investigated the accuracy of AI for the diagnosis of keratoconus. There were three different units of analysis in the studie... AI appears to be a promising triage tool in ophthalmologic practice for diagnosing keratoconus. Test accuracy was very high for manifest keratoconus and slightly lower for subclinical keratoconus, ind...

Biomechanics of keratoconus: Two numerical studies.

The steep cornea in keratoconus can greatly impair eyesight. The etiology of keratoconus remains unclear but early injury that weakens the corneal stromal architecture has been implicated. To explore ... A finite-element model describing the five corneal layers and the heterogeneous mechanical behaviors of the ground substance and lamellar collagen-fiber architecture in the anterior and posterior stro... Conical deformation and corneal thinning emerged when the corneal button or the mid-posterior stroma of the button underwent gradual softening or when the collagen fibers in the mid-posterior stroma o... These observations suggest that keratoconus could be initiated, at least partly, by mechanical instability/damage in the mid-posterior stroma that then imposes stress on the anterior layers. This may ...

Keratoconus tomographic indices in osteogenesis imperfecta.

Osteogenesis imperfecta (OI) is a rare inherited disease affecting collagen-rich tissues. Ocular complications have been reported such as thin corneas, low ocular rigidity, keratoconus, among others. ... Cross-sectional case-control study including 37 OI patients and 37 age-matched controls. Patients and controls underwent comprehensive ophthalmological examination including corneal Scheimpflug tomogr... Most OI patients had type I disease (n = 24; 65%) but type III-VII patients were also included. Two patients had clinically overt bilateral keratoconus. OI patients had significantly higher maximum ke... OI patients showed significant changes in corneal profiles compared with healthy subjects. A high proportion of patients had tomographically suspect corneas when using keratoconus diagnostic indices. ...

Keratoconus in two siblings with congenital distichiasis.

To describe a previously unreported association of keratoconus in congenital distichiasis.... Observational case series of ocular findings in 2 siblings with congenital distichiasis.... A 17-year-old male presented with tearing and photophobia in both eyes. His parents revealed that he was photophobic since birth. He had a lid surgery previously in both eyes. Clinical examination rev... Patients with congenital distichiasis may have associated keratoconus. Chronic ocular irritation and subsequent eye rubbing in distichiasis could be the risk factor for keratoconus....

Factors affecting quality of life in keratoconus.

To identify the factors affecting the quality of life (QoL) in adults with keratoconus, using the disease-specific Keratoconus Outcomes Research Questionnaire (KORQ).... In this cross-sectional study, 574 patients with keratoconus completed the 29-item KORQ (18-item activity limitations and 11-item symptoms subscales) and demographic information. Based on mean corneal... Mean (SD) age was 24.5 (5.1) years. 304 (53%), 160 (28%), 26 (4%) and 84 (15%) belonged to keratoconus groups 1, 2, 3 and 4, respectively. Rasch analysis demonstrated the 'activity limitations' and 's... People with keratoconus have poorer QoL in terms of activity limitations if they have poorer VA and greater wavefront aberrations, and in terms of symptoms if they are female and employed....

Clinical-epidemiological characteristics of keratoconus in Asturias.

Keratoconus is the most frequent corneal ectasia and second most common cause of keratoplasty worldwide. The clinical and epidemiological characteristics of keratoconus have rarely been studied in Spa... A cross-sectional study was conducted to analyze all cases of keratoconus diagnosed in the first consultations of the Cornea and Surface section of the Hospital Universitario Central de Asturias (Ovie... A total of 112 patients (42.0% women and 58.0% men) were included. The mean age was 36.84 ± 15.59, with 39.3% being older than 40 years. 31.8%, 28.0%, 15.0%, and 25.2% were in stages I, II, III and IV... Approximately 40% of keratoconus cases are detected at advanced stages and another 40% are detected at an age over 40 years. 13% of these patients require keratoplasty, which is why it is frequently p...

Analysis of Various Modalities for Intraocular Pressure Measurement in Relation to Keratoconus Severity in 246 Eyes of the Homburg Keratoconus Center.

Intraocular pressure (IOP) measurement may be difficult in keratoconus (KC) due to corneal protrusion and irregular astigmatism. This study aimed to assess which IOP measurement modality is least affe... Data from 246 corneas of 246 patients with KC were retrospectively analyzed. KC stages were determined using the Topographic KC (TKC) and ABCD KC classifications derived from Pentacam (Oculus, Germany... Using CA, the reliability of measurements using various modalities increased to 0.764 to 0.943 when excluding IOP Goldmann overall and in each KC stage (TKC and ABCD). Analysis of variance revealed si... CST-based bIOP seems to be best suited for IOP measurement in KC because it did not correlate with TCT in contrast to IOP measurements by ORA or GAT. The measurement results from GAT in patients with ...

Evaluation of parameters for early detection of pediatric keratoconus.

Keratoconus in children is often more severe and rapidly progressive compared to adults. While Scheimpflug imaging (Pentacam) improves screening, there are no established pediatric guidelines. Due to ... A single-center retrospective cohort analysis of patients 3-18 years screened for keratoconus with ophthalmic examination and initial Scheimpflug imaging between 2021 to 2023. Scheimpflug indices incl... Seventy-eight patients (11.8 ± 3.9 years) were screened with the majority referred due to high and/or progressive astigmatism (74 patients, 94%). Forty-nine patients (63%) were male and 48 (62%) self-... Older age, lower visual acuity, oblique astigmatism, and corneal findings were more commonly found in patients with abnormal screening Pentacam. Most patients clinically suspicious for keratoconus had...

Is there a relationship between the keratoconus and the peripapillary choroidal vasculature?

To evaluate the peripapillary/parapapillary choroidal vascular parameters in the keratoconus (KC) and to determine the relationship between topography parameters and the peripapillary/parapapillary ch... Ninety eyes of ninety patients with different stages of KC and 29 eyes of twenty-nine patients without KC were enrolled in the study. Patients with KC were divided into three groups according to the A... The retinal nerve fibre layer thickness (RNFLT) of the superior-temporal area and the pCVI were decreased in group 3 compared to the control group (superiror-temporal RNFLT: 122.27 ± 21.43 vs 139.90 ±... This study demonstrated that there may be changes in pCVI in patients with grade 3 KC and that there may be an association between pCVI and mean sim K. As KC grade increases, pCVI may decrease. Furthe...